Dina Johnson
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
-
- Ovarian cancer diagnosis and treatment 4
- Surgery 3
- Intraperitoneal and Appendiceal Malignancies 2
- Co-authors
- Robert Dreicer (1 shared paper)Patrick J. Loehrer (1 shared paper)Lawrence H. Einhorn (1 shared paper)Donna Neuberg (1 shared paper)Sidney Schultz (1 shared paper)Bruce J. Roth (1 shared paper)Jessica L. Smith (1 shared paper)G. R. Hudes (1 shared paper)
- Journals
- Gynecologic Oncology (2 papers)Journal of the American Medical Informatics Association (1 paper)Journal of Clinical Oncology (1 paper)Healthcare (1 paper)Retinal Cases & Brief Reports (1 paper)
- Partner nations
- United StatesMalawi
In The Last Decade
Dina Johnson
7 papers receiving 374 citations
Peers
Comparison fields: 5 of 57
- Reproductive Medicine 58
- Surgery 261
- Oncology 135
- Urology 16
- Biotechnology 17
Countries citing papers authored by Dina Johnson
This map shows the geographic impact of Dina Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Johnson more than expected).
Fields of papers citing papers by Dina Johnson
This network shows the impact of papers produced by Dina Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Johnson. The network helps show where Dina Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Dina Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 271 | |
| 2 | A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer. | 1997 | 49 |
| 3 | 1995 | 18 | |
| 4 | PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN PREVIOUSLY TREATED EPITHELIAL OVARIAN CANCER. A PHASE II TRIAL | 1992 | 16 |
| 5 | 2000 | 15 | |
| 6 | 2011 | 9 | |
| 7 | 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow. | 1999 | 6 |
| 8 | 2025 | 0 | |
| 9 | 2020 | 0 |
About Dina Johnson
Dina Johnson is a scholar working on Reproductive Medicine, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 9 papers that have together received 384 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Cancer Treatment and Pharmacology (1 paper), Breast Cancer Treatment Studies (1 paper), Glutathione Transferases and Polymorphisms (1 paper), Retinopathy of Prematurity Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Endometrial and Cervical Cancer Treatments (1 paper). The work is most often cited by research in Reproductive Medicine (58 citations), Surgery (261 citations), Oncology (135 citations), Urology (16 citations) and Biotechnology (17 citations). Dina Johnson has collaborated with scholars based in United States and Malawi. Frequent co-authors include Robert Dreicer, Patrick J. Loehrer, Lawrence H. Einhorn, Donna Neuberg, Sidney Schultz, Bruce J. Roth, Jessica L. Smith, G. R. Hudes, Jamie L. Dann and Mary‐Claire King. Their work appears in journals such as Gynecologic Oncology, Journal of the American Medical Informatics Association, Journal of Clinical Oncology, Healthcare and Retinal Cases & Brief Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.